“In 2000, the US drug company Mylan agreed to pay $147 million to settle accusations by the FTC that they had raised the price of generic lorazepam by 2600% and generic clorazepate by 3200% in 1998 after having obtained exclusive licensing agreements for certain ingredients.”
https://media.hachyderm.io/media_attachments/files/112/021/534/423/823/322/original/bf830951e04a4e6e.jpeg